Search results
Jump to navigation
Jump to search
- info - Home https://psychonautwiki.org/wiki/File:Behandeling-4-fa-intoxicatie.pdf https://psychonautwiki.org/wiki/File:4-FA%20risicobeoordeling%20(2016)21 KB (3,439 words) - 15:42, 30 July 2022
- In order to maintain consistency across the wiki, images of molecular structures should be produced in a standardized format rather than obtained from19 KB (857 words) - 09:55, 15 September 2022
- action involves promoting release of the neurotransmitters dopamine and norepinephrine. It was first synthesized in 1887, but its psychostimulant effects were41 KB (5,610 words) - 19:01, 7 April 2024
- acuminata - DMT-Nexus Wiki Acacia baileyana Wikipedia | https://en.wikipedia.org/wiki/Acacia_baileyana Acacia baileyana - DMT-Nexus Wiki Acacia burkittii70 KB (630 words) - 04:11, 16 May 2024
- releases a dopamine:norepinephrine ratio of ~1:1.3 from synapses versus ~1:2 for d-amphetamine. Their effect on the norepinephrine (NET) and dopamine (DAT)41 KB (5,798 words) - 13:29, 16 April 2024
- but it likely produces its effects by increasing levels of dopamine, norepinephrine, and serotonin in the brain. 4-FMA was first detected being sold in21 KB (3,467 words) - 16:14, 30 July 2022
- thought to act primarily as a potent norepinephrine-dopamine reuptake inhibitor. Reduced re-uptake of norepinephrine and dopamine results in higher concentrations23 KB (3,267 words) - 23:45, 21 April 2024
- produces its effects by promoting the release of serotonin, dopamine, and norepinephrine in the brain, particularly serotonin. MDMA was first developed in 191285 KB (10,499 words) - 14:24, 16 April 2024
- 6-APB is a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) with Ki values of 117, 150, and 2698 nM for the norepinephrine transporter (NET),33 KB (4,870 words) - 14:34, 16 April 2024
- are increasing concentrations of the neurotransmitters dopamine and norepinephrine by either promoting release (e.g. amphetamine, methamphetamine) or by11 KB (1,055 words) - 02:52, 12 May 2024
- MAOIs (MAOIs) Norepinephrine and dopamine reuptake inhibitors (NDRIs) Selective serotonin reuptake inhibitors (SSRIs) Serotonin and norepinephrine reuptake9 KB (1,069 words) - 21:47, 13 May 2024
- acts as a weak μ-opioid receptor agonist and a reuptake inhibitor of norepinephrine and serotonin. Tramadol was developed in 1962 and launched under the22 KB (3,211 words) - 19:11, 7 April 2024
- as a norepinephrine-dopamine reuptake inhibitor (NDRI). It is most active at modulating levels of dopamine and, to a lesser extent, norepinephrine. Methylphenidate31 KB (4,254 words) - 15:15, 6 May 2024
- through the interaction of the mu receptors with serotonin, dopamine, and norepinephrine. Activation of mu receptors allows for the disinhibition of serotonin19 KB (2,797 words) - 02:47, 12 May 2024
- mechanism of action is not fully studied, but dopamine and serotonin and norepinephrine releasing activity is known to be involved. 3-MMC first appeared on18 KB (2,590 words) - 21:20, 30 April 2024
- acts as both a dopamine and norepinephrine releasing agent. This means it effectively increases the levels of the norepinephrine and dopamine in the brain17 KB (2,934 words) - 17:24, 18 January 2024
- reuptake inhibitor and a norepinephrine reuptake inhibitor, meaning that it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters19 KB (2,684 words) - 18:04, 30 July 2022
- primarily as both a dopamine and norepinephrine releasing agent. This means it effectively increases the levels of the norepinephrine and dopamine neurotransmitters17 KB (3,024 words) - 17:25, 18 January 2024
- produces its activity by increasing the levels of serotonin, dopamine, and norepinephrine in the brain. The synthesis and pharmacology of 3-FPM was first reported15 KB (2,265 words) - 06:42, 8 September 2023
- mechanism of action involves increasing levels of serotonin, dopamine, and norepinephrine in the brain.[citation needed] Cocaine is one of the most widespread47 KB (6,322 words) - 08:08, 3 May 2024
- serotonin releasing agent (SSRA) with neglible effects on dopamine and norepinephrine. MDAI was developed by the American medicinal chemist and pharmacologist17 KB (2,560 words) - 07:40, 12 October 2023
- which includes compounds like MDPV, hexen, and a-PHP. It acts as a norepinephrine-dopamine reuptake inhibitor. α-PVP was patented in the 1960s by Boehringer24 KB (3,456 words) - 00:08, 3 November 2023
- dopamine reuptake inhibitor and norepinephrine reuptake inhibitor, meaning it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters18 KB (2,561 words) - 14:02, 16 April 2024
- promoting the release of the neurotransmitters serotonin, dopamine, and norepinephrine in the brain.[citation needed] Mephedrone was first synthesized in 192929 KB (3,963 words) - 14:23, 16 April 2024
- acts as both a dopamine and norepinephrine releasing agent. This means it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters12 KB (1,928 words) - 23:42, 21 April 2024
- Methylone acts as a mixed reuptake inhibitor/releasing agent of serotonin, norepinephrine, and dopamine. These neurotransmitters are thought to be responsible19 KB (2,841 words) - 14:21, 16 April 2024
- (Ecstasy). As with MDMA, MDA is thought to act primarily as a serotonin-norepinephrine-dopamine reuptake inhibitor and releasing agent.[citation needed] However31 KB (4,379 words) - 12:23, 6 May 2024
- likely similar to that of LSD, which acts on serotonin, dopamine, and norepinephrine receptors in the brain. 1V-LSD is a research chemical that appears to28 KB (3,658 words) - 15:27, 10 March 2023
- primarily as a dopamine and norepinephrine reuptake inhibitor, meaning it effectively boosts the levels of dopamine and norepinephrine neurotransmitters in the16 KB (2,465 words) - 15:45, 9 May 2024
- most likely acts as both a dopamine and norepinephrine reuptake inhibitor. This allows dopamine and norepinephrine to build up within the brain, resulting8 KB (961 words) - 23:45, 21 April 2024
- dementia. As with methylphenidate and pipradol, it is thought to act as a norepinephrine-dopamine reuptake inhibitor (NDRI). Of these three piperidines, it is19 KB (2,776 words) - 00:39, 1 August 2022
- of action, working on both the μ-opioid receptor and also acting as a norepinephrine reuptake inhibitor. Tapentadol is used in the management of moderate12 KB (2,182 words) - 23:51, 21 April 2024
- thought to act primarily as a mild norepinephrine-dopamine reuptake inhibitor. Reduced re-uptake of norepinephrine and dopamine results in higher concentrations11 KB (1,751 words) - 20:42, 12 September 2022
- dopamine and norepinephrine releasing agent, with modest selectivity for serotonin. This means it effectively increases the levels of the norepinephrine and dopamine15 KB (2,726 words) - 11:39, 17 February 2024
- activity on the α2 receptors in the brainstem inhibits the release of norepinephrine (NE), resulting in decreased sympathetic nervous system tone. Clonidine22 KB (2,932 words) - 13:49, 16 April 2024
- The mechanism of action involves promoting the release of dopamine and norepinephrine in the brain. Cyclazodone was developed in the 1960s by the American19 KB (2,675 words) - 16:54, 31 March 2024
- releaser of the monoamine neurotransmitters serotonin, dopamine, and norepinephrine. It has been demonstrated that compared to the unsubstituted ethylamphetamine19 KB (3,317 words) - 15:23, 30 July 2022
- promote dopamine, norepinephrine, histamine, and hypocretin / orexin. Modafinil and its R-enantiomer, armodafinil, increase both norepinephrine (NE) and dopamine19 KB (3,104 words) - 11:29, 16 April 2024
- serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) with very poor affinity for SERT. This allows dopamine, serotonin and norepinephrine to accumulate18 KB (2,677 words) - 06:56, 28 April 2024
- in effect. 5-MAPB is a triple reuptake inhibitor for the monoamines norepinephrine, dopamine and serotonin as well as being an agonist for the 5-HT2A and13 KB (2,233 words) - 00:32, 31 December 2022
- to the designer drug pentedrone and α-PVP, which both act as a potent norepinephrine-dopamine reuptake inhibitors (NDRI), although no substantial research21 KB (3,212 words) - 09:58, 30 May 2023
- and MDA. It produces its effects by increasing levels of serotonin, norepinephrine, and dopamine in the brain. The first recorded human use of MDEA was25 KB (3,654 words) - 23:46, 21 April 2024
- about its pharmacology, although it likely acts by increasing levels of norepinephrine and dopamine in the brain. N-Ethylhexedrone was first synthesized by25 KB (3,455 words) - 23:45, 21 April 2024
- and that it releases the neurotransmitters: serotonin, dopamine, and norepinephrine. 2-FEA likely creates it effects by acting as a releasing agent of said13 KB (1,917 words) - 18:16, 30 April 2024
- its effects by promoting the release of neurotransmitters dopamine and norepinephrine in the brain. Subjective effects are essentially identical to that of23 KB (3,617 words) - 09:16, 17 April 2024
- produces its effects by increasing levels of serotonin, dopamine, and norepinephrine in the brain. Ephylone was developed in the 1960s by Boehringer Ingelheim17 KB (2,604 words) - 22:15, 31 July 2022
- acts as both a dopamine and norepinephrine releasing agent. This means it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters11 KB (1,914 words) - 23:46, 21 April 2024
- should be adjusted accordingly. 5-APB is a triple reuptake inhibitor for norepinephrine, dopamine and serotonin as well as being an agonist for the 5-HT2A14 KB (2,336 words) - 23:43, 21 April 2024
- acts as a dopamine and norepinephrine reuptake inhibitor, meaning it effectively boosts the levels of dopamine and norepinephrine neurotransmitters in the24 KB (3,701 words) - 23:42, 21 April 2024
- (family Ephedraceae). It works mainly by increasing the activity of norepinephrine (noradrenaline) on adrenergic receptors. It is most usually marketed13 KB (1,767 words) - 16:46, 7 April 2024
- a dopamine and norepinephrine reuptake inhibitor. It however has been shown that ETH-CAT is a selective substrate for the norepinephrine transporter (NET)17 KB (2,584 words) - 12:23, 5 April 2024
- non-essential amino acid that serves a precursor to dopamine, adrenaline and norepinephrine in the human body. As a supplement, it is reported to act as a mild14 KB (2,109 words) - 23:22, 21 April 2024
- and, in high doses, on norepinephrine, and to a small extent epinephrine, glutamate, and cortisol. Caffeine increases norepinephrine by about 75%, dopamine29 KB (3,603 words) - 00:00, 10 May 2024
- group of compounds known as substituted cathinones. Pentedrone acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). Pentedrone was first detected being17 KB (2,503 words) - 00:26, 6 May 2024
- Methiopropamine functions as a selective norepinephrine-dopamine releasing agent. This allows dopamine and norepinephrine to accumulate within the brain, resulting13 KB (2,010 words) - 00:43, 1 August 2022
- concentration. Norepinephrine release causes increased alertness and arousal. With low doses, nicotine enhances the action of norepinephrine and dopamine53 KB (5,335 words) - 06:57, 15 May 2024
- promote dopamine, norepinephrine, histamine, and hypocretin / orexin. Modafinil and its R-enantiomer, armodafinil, increase both norepinephrine (NE) and dopamine18 KB (3,163 words) - 18:25, 30 April 2024
- Butylone acts as a mixed reuptake inhibitor/releasing agent of serotonin, norepinephrine, and dopamine. These are the neurotransmitters in charge of pleasure18 KB (2,647 words) - 23:46, 21 April 2024
- Ethylone acts as a mixed reuptake inhibitor/releasing agent of serotonin, norepinephrine, and dopamine. These are the neurotransmitters in charge of pleasure17 KB (2,532 words) - 22:27, 31 July 2022
- inhibiting the metabolism of monoamine compounds such as serotonin and norepinephrine. Harmala alkaloids are selective for MAO-A at reasonable doses and bind13 KB (1,772 words) - 02:21, 24 September 2023
- dopaminergic stimulant and likely is the result of activity beyond dopamine and norepinephrine reuptake inhibition. Even in high doses it is much less stimulating17 KB (2,757 words) - 17:49, 30 July 2022
- acts primarily as a triple releasing agent of serotonin, dopamine, and norepinephrine.[citation needed] Disclaimer: The effects listed below cite the Subjective14 KB (2,687 words) - 15:28, 30 July 2022
- central nervous system is the blockade of the serotonin, dopamine, and norepinephrine transporter. This substance acts as a triple reuptake inhibitor and20 KB (2,747 words) - 00:19, 1 August 2022
- DXM should be avoided due to its inhibiting effects on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive26 KB (4,015 words) - 23:44, 21 April 2024
- inhibitor and releasing agent of the main three monoamines; serotonin, norepinephrine, and dopamine, and as a non-selective serotonin receptor agonist. αMT's25 KB (2,825 words) - 16:14, 28 November 2022
- neurotransmitters are derived from phenethylamine such as adrenaline, dopamine, norepinephrine. Disclaimer: The effects listed below cite the Subjective Effect Index7 KB (919 words) - 17:25, 24 November 2023
- α1-adrenergic, α2-adrenergic, H1, I1 (Imidazoline receptor), and NET (norepinephrine transporter). It behaves as an agonist at most serotonin receptors.18 KB (2,483 words) - 19:42, 10 October 2023
- selective serotonin releasing agent (SSRA) with weak effects on dopamine and norepinephrine transporters. However, relative to MDMA, it is considerably less effective10 KB (1,254 words) - 09:30, 28 December 2022
- neurotransmitters, including glutamate, substance P, acetylcholine, and norepinephrine. This, in turn, increases GABAergic activity.[citation needed] As the12 KB (1,795 words) - 20:04, 18 November 2023
- DXM should be avoided due to its inhibiting effects on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive8 KB (1,534 words) - 19:22, 2 August 2022
- acting as a releasing agent for the monoamine neurotransmitters dopamine, norepinephrine, and serotonin (SNDRA), binding to and reversing their transporters20 KB (2,813 words) - 21:23, 25 October 2023
- results. Ephenidine also possesses weaker affinity for the dopamine and norepinephrine transporters (379 nM and 841 nM, respectively) as well as σ1R (629 nM)25 KB (3,096 words) - 09:43, 10 May 2024
- neurotransmitters, including dopamine, acetylcholine, serotonin, and, in high doses, norepinephrine, and to a small extent epinephrine, glutamate, and cortisol. The effects10 KB (1,245 words) - 19:38, 30 April 2024
- attention-promoting effects of kava. Kavain has shown evidence to be a serotonin-norepinephrine reuptake inhibitor (SNRI). It also shows evidence of being an activator12 KB (1,783 words) - 07:02, 29 October 2023
- presents affinity for the norepinephrine and serotonin receptor systems where it functions as an agonist. Its action on norepinephrine and serotonin also likely42 KB (6,087 words) - 13:21, 16 April 2024
- addition to inhibiting dopamine reuptake. It also increases levels of norepinephrine, but its means of doing so are unclear. Bromantane's anxiolytic properties14 KB (1,794 words) - 23:23, 21 April 2024
- concentrations of neurotransmitters such as serotonin, dopamine and norepinephrine through unknown mechanisms. These substances include but are not limited21 KB (2,764 words) - 23:36, 21 April 2024
- a wide range of monoamine receptors, such as those for dopamine and norepinephrine. However, there is currently no data to support these claims. Owing27 KB (3,642 words) - 18:48, 12 November 2022
- to the SERT and NET, thereby acting as a moderately potent serotonin-norepinephrine reuptake inhibitor. These mechanisms may help explain why there are22 KB (2,938 words) - 21:31, 14 November 2023
- receptor antagonist. Pethidine is also a dopamine reuptake inhibitor and norepinephrine reuptake inhibitor. Pethidine is a κ-opioid agonist and its metabolite13 KB (2,295 words) - 12:34, 29 April 2024
- selective serotonin releasing agent (SSRA) with weak effects on dopamine and norepinephrine transporters. However, relative to MDMA, it is considerably less effective10 KB (2,183 words) - 19:02, 2 August 2022
- serotonin reuptake inhibitors, but (−)-O-DSMT retains activity as a norepinephrine reuptake inhibitor, and so the mix of both the parent compound and metabolites13 KB (2,437 words) - 07:14, 27 December 2023
- binding profiles at monoamine receptors (i.e. serotonin, dopamine, and norepinephrine).[citation needed] One study found MiPLA to fully substitute for LSD21 KB (2,783 words) - 04:48, 30 June 2022
- monoamine receptors other than serotonin, specifically dopamine and norepinephrine. The most prominent of these cognitive effects generally include: Analysis35 KB (4,592 words) - 06:53, 10 December 2023
- have shown that LSD possesses binding efficacy at all dopamine and all norepinephrine receptors. Most serotonergic psychedelics are not significantly dopaminergic100 KB (12,100 words) - 08:20, 3 January 2024
- DXM should be avoided due to its inhibiting effects on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive9 KB (1,564 words) - 23:45, 21 April 2024
- DXM should be avoided due to its inhibiting effects on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive10 KB (1,757 words) - 23:45, 21 April 2024
- a wide range of monoamine receptors, such as those for dopamine and norepinephrine. However, there is currently no experimental data to support these claims36 KB (4,688 words) - 09:41, 10 May 2024
- neurotransmitters, including glutamate, substance P, acetylcholine and norepinephrine. Reduction in the release of glutamate and acetylcholine might be the41 KB (5,211 words) - 12:50, 15 March 2024
- a wide range of monoamine receptors, such as those for dopamine and norepinephrine. However, there is currently no data to support these claims. It has31 KB (4,078 words) - 22:48, 15 April 2023
- Template health overview (category PsychonautWiki)Serotonin-norepinephrine reuptake inhibitor Serotonin-norepinephrine reuptake inhibitor/Summary Template:SubstanceBox/Serotonin-norepinephrine reuptake1 KB (0 words) - 21:34, 18 January 2022
- List of articles (category PsychonautWiki)L-Phenylalanine Dopamine Epinephrine (Adrenaline) Histamine Melatonin Norepinephrine (Noradrenaline) Serotonin (5-HT) Catecholamines Dopamine Phenethylamines502 bytes (5,908 words) - 20:25, 10 June 2017